Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP623037.RAb8pmGjtd-3zqnB6qLb6bDmQfbk8m-Uhc8FvQomd5mFA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP623037.RAb8pmGjtd-3zqnB6qLb6bDmQfbk8m-Uhc8FvQomd5mFA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP623037.RAb8pmGjtd-3zqnB6qLb6bDmQfbk8m-Uhc8FvQomd5mFA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP623037.RAb8pmGjtd-3zqnB6qLb6bDmQfbk8m-Uhc8FvQomd5mFA130_provenance.
- NP623037.RAb8pmGjtd-3zqnB6qLb6bDmQfbk8m-Uhc8FvQomd5mFA130_assertion description "[Alterations in the phosphoinositide 3-kinase/AKT/mammalian target of rapamycin (PI3K/AKT/mTOR) signalling pathway are frequent in urothelial bladder cancer (BLCA) and thus provide a potential target for novel therapeutic strategies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP623037.RAb8pmGjtd-3zqnB6qLb6bDmQfbk8m-Uhc8FvQomd5mFA130_provenance.
- NP623037.RAb8pmGjtd-3zqnB6qLb6bDmQfbk8m-Uhc8FvQomd5mFA130_assertion evidence source_evidence_literature NP623037.RAb8pmGjtd-3zqnB6qLb6bDmQfbk8m-Uhc8FvQomd5mFA130_provenance.
- NP623037.RAb8pmGjtd-3zqnB6qLb6bDmQfbk8m-Uhc8FvQomd5mFA130_assertion SIO_000772 25349966 NP623037.RAb8pmGjtd-3zqnB6qLb6bDmQfbk8m-Uhc8FvQomd5mFA130_provenance.
- NP623037.RAb8pmGjtd-3zqnB6qLb6bDmQfbk8m-Uhc8FvQomd5mFA130_assertion wasDerivedFrom befree-20150227 NP623037.RAb8pmGjtd-3zqnB6qLb6bDmQfbk8m-Uhc8FvQomd5mFA130_provenance.
- NP623037.RAb8pmGjtd-3zqnB6qLb6bDmQfbk8m-Uhc8FvQomd5mFA130_assertion wasGeneratedBy ECO_0000203 NP623037.RAb8pmGjtd-3zqnB6qLb6bDmQfbk8m-Uhc8FvQomd5mFA130_provenance.
- befree-20150227 importedOn "2015-02-27" NP623037.RAb8pmGjtd-3zqnB6qLb6bDmQfbk8m-Uhc8FvQomd5mFA130_provenance.